Cytokine profiles in the central nervous system and the spleen during the early course of experimental African trypansomiasis

Scandinavian Journal of Immunology

Volumn 50, Issue 3, 1999, Pages 256-261

  Sharafeldin, Ahmed ^a   Hamadien, M ^b   Diab, A ^b   Li, H L ^a   Shi, F D ^a   Bakhiet, M ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN; TRYPANOSOMA BRUCEI; TRYPANOSOMIASIS;

ANIMALS; CENTRAL NERVOUS SYSTEM; CYTOKINES; DISEASE MODELS, ANIMAL; INTERLEUKIN-10; INTERLEUKIN-4; MALE; RATS; RATS, SPRAGUE-DAWLEY; SPLEEN; TRANSFORMING GROWTH FACTOR BETA; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032788241     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1999.00600.x     Document Type: Article

References (36)

1. 1 Evens F, Marsboom R, Mortelmans J. Experimental infection with Trypanoxoma brucei, Trypanosoma rhodiense and Trypanosoma gambiense in beagle dogs. Trans R Soc Trop Med Hyg 1970;64:161-2.
2. 2 Schultzberg M, Ambatsis M, Samuelsson E-B, Kristensson K, Van Meirvenne N. Spread of Trypanosoma brucei to the nervous system: early attack on circumventricular organs and sensory ganglia. J Neurosci Res 1988;21:56-61.
3. + T cells supresses growth of Trypanosoma brucei brucei and interferon-gamma production in infected rats. Clin Exp Immunol 1990;81:195-9.
4. 4 Dumas M, Boutelle B. Human African Trypanosomiasis (review). Comptes Rendus Seances de la Biologie de Ses Filiales 1996;190:395-408.
5. 5 Campbell IL, Stalder AK, Chiang CS et al. Transgenic models to assess the pathogenic actions of cytokines in the centeral nervous system. Mol Psychiatry 1997;2:125-9.
6. 6 Cox FEG, Liew FY. T-cell subsets and cytokines in parasitic infections. Immunol Today 1992;13:445-8.
7. + lymphocytes to interferon gamma secretion: purification, characterization and protective effects in vivo by treatment with monoclonal antibodies against the factor. Scand J Immunol 1993;37:165-78.
8. 8 Olsson T, Bakhiet M, Hojeberg B et al. CD8 is critically involved in lymphocyte activation by a Trypanosoma brucei brucei released molecule. Cell 1993;72:715-27.
9. 9 Bakhiet M, Olsson T, Mhlanga P et al. Human and rodent IFN-γ as a growth factor for Trypanosoma brucei brucei. Eur J Immunol 1996;26:1359-64.
10. 10 Lucas R, De Magez S, Leys R et al. Mapping the lectin-like activity of tumor necrosis factor. Science 1994;263:814-7.
11. 11 Bakhiet M, Jansson L, Büscher P, Holmdahl R, Kristensson K, Olsson T. Control of parasitemia and survival during Trypanosoma brucei brucei infection is related to strain dependent ability to produce interleukin-4. J Immunol 1996;157:3518-26.
12. 12 Black SJ, Sendashonga CN, Brien CO et al. Regulation of parasitaemia in mice infected with Trypanosoma brucei. Current Topics Microbiol Immunol. Heidelberg: Springer-Verlag Berlin, 1985:93-118.
13. 13 Dagerlind A, Bean KAJ, Hokfelt T. Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry. Histochemistry 1992;98:39-49.
14. 14 Zhu J, Mix E, Olsson T, Link H. Cellular mRNA expression of interferon-γ, interleukin-4 and transforming growth factor-β, by rat mononuclear cells stimulated with peripheral nerve myelin antigens in experimental allergic neuritis. Clin Exp Immunol 1994;8:306-12.
15. 15 Eltayeb R, Mustafa M, Kristensson K et al. Cytokines and anti-cytokine autoantibodies during experimental African trypanosomiasis in mice with disrupted interferon-γ and interferon-γ receptor genes. Int J Mol Med 1998;1:177-83.
16. 16 Bakhiet M, Diab A, Mustafa M, Zhu J, Lindquist L, Link H. Potential role of autoantibodies in the regulation of cytokine responses in bacterial infections. Infect Immun 1997;65:3300-3.
17. 17 Kaplow LS. Substitute of benzidine in myeloperoxidase stains. Am J Clinic Pathol 1974;63:4511.
18. 18 Skoskiewicz MJ, Calvin RB, Schneeberger EE, Russel PS. Widespread and selective induction of major histocompatibility complex determined antigens in vivo by gamma interferon. J Exp Med 1985;162:1645-64.
19. 19 Adams DO, Hamilton TA. Molecular transductional mechanisms by which IFN-γ and other signals regulate macrophage development. Immunol Rev 1987;97:5-27.
20. 20 Goldberg M, Belkowski LS, Bloom BR. Regulation of macrophage function by interferon-γ. Somatic cell genetic approaches in murine machrophage cell lines to mechanisms of growth inhibition, the oxidative burst, and the expression of the chronic granulomatous disease gene. J Clin Invest 1990;85:563-9.
21. 21 Young VW, Moumdjian RA, Young FP, Antel JP. Gamma-interferon is a gliosis-inducing cytokine. Neurology 1991;41:189.
22. 22 Erkrnan I, Wuarin I, Cadell D, Kato AC. Interferon induces astrocyte maturation causing an increase in cholinergic properties of cultured human spinal cord cells. Dev Bio 1989;132:375-88.
23. 23 Shull MM, Ormsby I, Kier AB et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 1992;395:693-9.
24. 24 Espevik T, Figari IS, Shalaby MR, Lackides GD, Shepard HM, Palladino MA. Inhibition of cytokine production by cyclosporin A and transforming growth factor-β. J Exp Med 1987;166:571-6.
25. 25 Askonas BA, Corsini AC, Clayton CE, Ogilvie BM. Functional depletion of T-and B-memory cells and other lymphoid cell subpopulation-during Trypanosomiasis. Immunology 1979;36:313-21.
26. 26 Bakhiet M, Olsson T, Ljungdahl Å et al. Induction of interferon-gamma, transforming growth factor-beta and interleukin-4 in mouse strains with different susceptibility to Trypanosoma brucei brucei. J InterfCytok Res 1996;16:427-33.
27. 27 Cohen AH, Nast CC. TGF-beta in renal allograft rejection. Miner Electrolyte Metab 1998;24:197-201.
28. 28 Yamate J, Okado A, Kuwamura M et al. Immunohistochemical analysis of macrophages, myfibroblasts, and transforming growth factor-beta localisation during rat renal interstitial fibrosis following long-term unilateral ureteral obstruction. Toxicologic Pathol 1998;26:793-801.
29. 29 Kuruvilla AP, Shah R, Hochwald GM, Liggitt HD, Palladino MA, Thorbecke GJ. Protective effect of transforming growth factor β-1 on experimental autoimmune encephalomylitis in mice. Proc Natl Acad Sci USA 1991;88:2918-21.
30. 30 Racke MK, Dhib-Jalbut S, Cannella B, Albert PS, Raine CS, McFarlin DE. Prevention and treatment of chronic relapsing experimental allergic encephalomylitis by transforming growth factor-β1. Immunol 1991;146:3012-7.
31. 31 van Velthuysen ML, Bruijn JA, van Leer EH, Fleuren GJ. Pathogenesis of trypanosomiasis-induced glomerulonephritis in mice. Nephrol Dial Transplant 1992;7:507-15.
32. 32 Bitzer M, Sterzel RB, Bottinger EP. Transforming growth factor-beta in renal disease. Kidney Blood Pressure Res 1998;21:1-12.
33. 33 Ramilo O, Saez-Liorens X, Mertsola J et al. Tumour necrosis factor-α/cachectin and interleukin-1β initiate meningeal inflammation. J Exp Med 1990;172:497-507.
34. 34 Fiorentino DF, Zlotnik A, Mosmann TR, Howard MO, Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-22.
35. 35 Frei K, Lius K, Schmedel C, Fontana A. Antigen presentation in the CNS. The inhibitory effect of IL-10 on MHC class expression and production of cytokines depends on inducing signals and the type of cell analyses. Immunology 1994;152:2720-8.
36. 36 Constam DB, Phillipp J, Malipiero KV, Ten Dijke P, Schachner M, Fontana A. Differential expression of transforming growth factor-beta 1, -beta 2 and beta 3 by glioblastoma cells, astrocytes and microglia. J Immunol 1992;148:1404-10.